Healthcare May 24, 2022 03:26 AM (GMT+8) · EqualOcean
Henrik juuel, chief financial officer of Bavarian Nordic A / s, a Danish vaccine manufacturer, said in a recent telephone interview that the company could increase its annual production to 30 million doses if necessary. Juuel added that if the demand exceeds 30 million doses, the company may sign contracts with other vaccine manufacturers to expand production capacity, but the process still takes six to 12 months. The vaccine jynneos developed by Bavarian Nordic is the only monkeypox vaccine approved in Europe and America.